Spero Therapeutics, Inc.
Cambridge, MA Spero
- UEI
- NX34PL7NZW24
- CAGE
- 7SK81
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Spero Therapeutics, Inc.
NX34PL7NZW24
- Spero Legacy Sti, Inc. VV22G4K3AZC4
-
Spero Therapeutics, Inc.
NX34PL7NZW24
- SAM.gov registration date
- Physical address
- 675 Massachusetts Ave, Cambridge, MA 02139, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| To advance clinical and non-clinical development of an antibiotic candidate. | National Institute of Allergy and Infectious Diseases | $10,501,521 | |
| Development of SPR206, a direct acting polymyxin antibiotic with reduced nephrotoxicity, to treat multidrug-resistant… | Defense Health Agency | $5,882,265 | |
| Deobligate and close out the contract | Office of the Assistant Secretary for Preparedness and Response | $49,196,134 | |
| - "development of a second generation polymyxin for therapy of MDR gram-negative infections" | National Institute of Allergy and Infectious Diseases | $5,923,719 |
Quick answers
What is Spero Therapeutics, Inc.'s UEI?
Spero Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is NX34PL7NZW24.
What is Spero Therapeutics, Inc.'s CAGE code?
Spero Therapeutics, Inc.'s CAGE code is 7SK81.
What is Spero Therapeutics, Inc.'s primary NAICS code?
Spero Therapeutics, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Spero Therapeutics, Inc. located?
Spero Therapeutics, Inc.'s physical address in SAM.gov is 675 Massachusetts Ave, Cambridge, MA 02139, USA.
Is Spero Therapeutics, Inc. registered in SAM.gov?
Yes. Spero Therapeutics, Inc.'s SAM.gov registration is active through July 2, 2027.
What is Spero Therapeutics, Inc.'s most recent federal award?
Spero Therapeutics, Inc.'s most recent federal contract award is To advance clinical and non-clinical development of an antibiotic candidate (75N93021C00022), from National Institute of Allergy and Infectious Diseases, on May 17, 2021.
On GovTribe
See Spero Therapeutics, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors